Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors - PubMed (original) (raw)
. 1992 Apr 3;256(5053):102-5.
doi: 10.1126/science.1566048.
Affiliations
- PMID: 1566048
- DOI: 10.1126/science.1566048
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors
D Sidransky et al. Science. 1992.
Abstract
Colorectal (CR) tumors are usually curable if detected before metastasis. Because genetic alterations are associated with the development of these tumors, mutant genes may be found in the stool of individuals with CR neoplasms. The stools of nine patients whose tumors contained mutations of K-ras were analyzed. In eight of the nine cases, the ras mutations were detectable in DNA purified from the stool. These patients included those with benign and malignant neoplasms from proximal and distal colonic epithelium. Thus, colorectal tumors can be detected by a noninvasive method based on the molecular pathogenesis of the disease.
Similar articles
- Detecting colorectal cancer in stool with the use of multiple genetic targets.
Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, Hibi K, Goodman SN, D'Allessio M, Paty P, Hamilton SR, Sidransky D, Barany F, Levin B, Shuber A, Kinzler KW, Vogelstein B, Jen J. Dong SM, et al. J Natl Cancer Inst. 2001 Jun 6;93(11):858-65. doi: 10.1093/jnci/93.11.858. J Natl Cancer Inst. 2001. PMID: 11390535 - Prognostic significance of K-ras mutations in colorectal carcinoma.
Benhattar J, Losi L, Chaubert P, Givel JC, Costa J. Benhattar J, et al. Gastroenterology. 1993 Apr;104(4):1044-8. doi: 10.1016/0016-5085(93)90272-e. Gastroenterology. 1993. PMID: 8462792 - [Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].
Koornstra JJ, Røkke O, Halvorsen JF, Haug K, Ogreid D. Koornstra JJ, et al. Tidsskr Nor Laegeforen. 1995 Oct 30;115(26):3266-70. Tidsskr Nor Laegeforen. 1995. PMID: 7482456 Review. Norwegian. - Identification of colon cancer patients by molecular diagnosis.
Müller O. Müller O. Dig Dis. 2003;21(4):315-9. doi: 10.1159/000075354. Dig Dis. 2003. PMID: 14752221 Review.
Cited by
- Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers.
Mondal D, Shinde S, Sinha V, Dixit V, Paul S, Gupta RK, Thakur S, Vishvakarma NK, Shukla D. Mondal D, et al. Front Mol Biosci. 2024 May 6;11:1385238. doi: 10.3389/fmolb.2024.1385238. eCollection 2024. Front Mol Biosci. 2024. PMID: 38770216 Free PMC article. Review. - Application of noninvasive sampling technique in mitochondrial genome intraspecific phylogeny of the endangered butterfly, Teinopalpus aureus (Lepidoptera: Papilionidae).
Yang WJ, He GQ, Huang CB, Zhou SY, Jia FH, Zeng JP. Yang WJ, et al. J Insect Sci. 2024 Jan 1;24(1):16. doi: 10.1093/jisesa/ieae008. J Insect Sci. 2024. PMID: 38412293 Free PMC article. - Optimization of screening strategies for colorectal cancer based on fecal DNA and occult blood testing.
Yao T, Sun Q, Xiong K, Su Y, Zhao Q, Zhang C, Zhang L, Li X, Fang H. Yao T, et al. Eur J Public Health. 2023 Apr 1;33(2):336-341. doi: 10.1093/eurpub/ckad032. Eur J Public Health. 2023. PMID: 36905607 Free PMC article. - Current concepts of anti-EGFR targeting in metastatic colorectal cancer.
Doleschal B, Petzer A, Rumpold H. Doleschal B, et al. Front Oncol. 2022 Nov 17;12:1048166. doi: 10.3389/fonc.2022.1048166. eCollection 2022. Front Oncol. 2022. PMID: 36465407 Free PMC article. Review. - New Perspectives on the Importance of Cell-Free DNA Biology.
Bronkhorst AJ, Ungerer V, Oberhofer A, Gabriel S, Polatoglou E, Randeu H, Uhlig C, Pfister H, Mayer Z, Holdenrieder S. Bronkhorst AJ, et al. Diagnostics (Basel). 2022 Sep 3;12(9):2147. doi: 10.3390/diagnostics12092147. Diagnostics (Basel). 2022. PMID: 36140548 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous